UniProt ID | UBP3_HUMAN | |
---|---|---|
UniProt AC | Q9Y6I4 | |
Protein Name | Ubiquitin carboxyl-terminal hydrolase 3 | |
Gene Name | USP3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 520 | |
Subcellular Localization | Nucleus . Localizes preferentially with monoubiquitinated H2A to chromatin. | |
Protein Description | Hydrolase that deubiquitinates monoubiquitinated target proteins such as histone H2A and H2B. Required for proper progression through S phase and subsequent mitotic entry. May regulate the DNA damage response (DDR) checkpoint through deubiquitination of H2A at DNA damage sites. Associates with the chromatin.. | |
Protein Sequence | MECPHLSSSVCIAPDSAKFPNGSPSSWCCSVCRSNKSPWVCLTCSSVHCGRYVNGHAKKHYEDAQVPLTNHKKSEKQDKVQHTVCMDCSSYSTYCYRCDDFVVNDTKLGLVQKVREHLQNLENSAFTADRHKKRKLLENSTLNSKLLKVNGSTTAICATGLRNLGNTCFMNAILQSLSNIEQFCCYFKELPAVELRNGKTAGRRTYHTRSQGDNNVSLVEEFRKTLCALWQGSQTAFSPESLFYVVWKIMPNFRGYQQQDAHEFMRYLLDHLHLELQGGFNGVSRSAILQENSTLSASNKCCINGASTVVTAIFGGILQNEVNCLICGTESRKFDPFLDLSLDIPSQFRSKRSKNQENGPVCSLRDCLRSFTDLEELDETELYMCHKCKKKQKSTKKFWIQKLPKVLCLHLKRFHWTAYLRNKVDTYVEFPLRGLDMKCYLLEPENSGPESCLYDLAAVVVHHGSGVGSGHYTAYATHEGRWFHFNDSTVTLTDEETVVKAKAYILFYVEHQAKAGSDKL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MECPHLSS -------CCCCCCCC | 12.34 | 19413330 | |
16 | Phosphorylation | SVCIAPDSAKFPNGS CEEECCCCCCCCCCC | 32.09 | 23401153 | |
23 | Phosphorylation | SAKFPNGSPSSWCCS CCCCCCCCCCCCCHH | 28.40 | 28985074 | |
36 | Acetylation | CSVCRSNKSPWVCLT HHHHCCCCCCEEEEE | 60.17 | 25953088 | |
37 | Phosphorylation | SVCRSNKSPWVCLTC HHHCCCCCCEEEEEC | 28.39 | 25159151 | |
59 | Ubiquitination | YVNGHAKKHYEDAQV CCCCCHHHHCCCCCC | 52.80 | - | |
61 | Phosphorylation | NGHAKKHYEDAQVPL CCCHHHHCCCCCCCC | 25.12 | 22817900 | |
69 | Phosphorylation | EDAQVPLTNHKKSEK CCCCCCCCCCCCCCC | 29.25 | 28555341 | |
72 | Ubiquitination | QVPLTNHKKSEKQDK CCCCCCCCCCCCCCC | 61.13 | - | |
74 | Phosphorylation | PLTNHKKSEKQDKVQ CCCCCCCCCCCCCCC | 55.63 | - | |
93 | Phosphorylation | MDCSSYSTYCYRCDD CCCCCCCCEEEECCC | 14.91 | - | |
107 | Sumoylation | DFVVNDTKLGLVQKV CEEECCCHHHHHHHH | 43.34 | - | |
107 | Ubiquitination | DFVVNDTKLGLVQKV CEEECCCHHHHHHHH | 43.34 | - | |
107 | Sumoylation | DFVVNDTKLGLVQKV CEEECCCHHHHHHHH | 43.34 | - | |
113 | Ubiquitination | TKLGLVQKVREHLQN CHHHHHHHHHHHHHH | 35.46 | - | |
124 | Phosphorylation | HLQNLENSAFTADRH HHHHHHHCCCCCHHH | 18.51 | 22496350 | |
127 | Phosphorylation | NLENSAFTADRHKKR HHHHCCCCCHHHHHH | 27.62 | 28555341 | |
132 | Ubiquitination | AFTADRHKKRKLLEN CCCCHHHHHHHHHHC | 55.99 | - | |
135 | Ubiquitination | ADRHKKRKLLENSTL CHHHHHHHHHHCCCC | 67.32 | - | |
140 | Phosphorylation | KRKLLENSTLNSKLL HHHHHHCCCCCCEEE | 25.54 | 28555341 | |
141 | Phosphorylation | RKLLENSTLNSKLLK HHHHHCCCCCCEEEE | 41.35 | 22817900 | |
145 | Acetylation | ENSTLNSKLLKVNGS HCCCCCCEEEEECCC | 57.68 | 25953088 | |
145 | Ubiquitination | ENSTLNSKLLKVNGS HCCCCCCEEEEECCC | 57.68 | 21906983 | |
148 | Ubiquitination | TLNSKLLKVNGSTTA CCCCEEEEECCCCCE | 44.05 | - | |
210 | Phosphorylation | RRTYHTRSQGDNNVS CCCEECCCCCCCCCC | 39.40 | 29978859 | |
217 | Phosphorylation | SQGDNNVSLVEEFRK CCCCCCCCHHHHHHH | 28.90 | 23186163 | |
333 | Ubiquitination | ICGTESRKFDPFLDL ECCCCCCCCCCCCCC | 64.50 | 21906983 | |
350 | Phosphorylation | DIPSQFRSKRSKNQE CCCHHHHCCCCCCCC | 33.44 | 25627689 | |
354 | Methylation | QFRSKRSKNQENGPV HHHCCCCCCCCCCCC | 67.68 | 30800147 | |
354 | Ubiquitination | QFRSKRSKNQENGPV HHHCCCCCCCCCCCC | 67.68 | - | |
363 | Phosphorylation | QENGPVCSLRDCLRS CCCCCCCCHHHHHHH | 27.03 | - | |
372 | Phosphorylation | RDCLRSFTDLEELDE HHHHHHCCCHHHCCC | 40.70 | - | |
387 | Ubiquitination | TELYMCHKCKKKQKS CCHHHHHHCCCCCCC | 42.70 | - | |
389 | Ubiquitination | LYMCHKCKKKQKSTK HHHHHHCCCCCCCCC | 68.74 | - | |
423 | Ubiquitination | WTAYLRNKVDTYVEF HHHHHHCCCCEEEEE | 34.75 | 21906983 | |
423 | Ubiquitination | WTAYLRNKVDTYVEF HHHHHHCCCCEEEEE | 34.75 | 21890473 | |
426 | Phosphorylation | YLRNKVDTYVEFPLR HHHCCCCEEEEEECC | 32.24 | 28152594 | |
427 | Phosphorylation | LRNKVDTYVEFPLRG HHCCCCEEEEEECCC | 8.10 | 28152594 | |
517 | Phosphorylation | EHQAKAGSDKL---- HHHHHHCCCCC---- | 36.11 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of UBP3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UBP3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UBP3_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-141, AND MASSSPECTROMETRY. |